You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
德国CureVac启动新冠疫苗中期临床测试 美国Moderna疫苗在老年人奏效
阿思达克 09-30 10:03
德国生物科技公司CureVac(CVAC.US)已启动新冠疫苗中期临床测试,并计划在第四季展开更大规模测试,预计约有3万名志愿人士参与。

在消息公布後,CureVac盘後股价急升8.12%。CureVac本月从德国政府获得近3亿美元的资金,以加快研发疫苗并建设生产疫苗的设施。

另外,美国生物科技大厂Moderna(MRNA.US)的最新新冠疫苗研究显示,该疫苗在老年人身上所产生的抗体水平与年轻人相若;副作用亦大致与接受高剂量流感疫苗相若。

Moderna股价於在盘後上升4.93%,报74美元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account